CG Oncology, Inc. (CGON)
NASDAQ: CGON · IEX Real-Time Price · USD
35.22
-1.50 (-4.08%)
At close: Jul 19, 2024, 4:00 PM
35.23
+0.01 (0.03%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CG Oncology Employees
CG Oncology had 61 employees as of December 27, 2023.
Employees
61
Change
n/a
Growth
n/a
Revenue / Employee
$8,836
Profits / Employee
-$932,328
Market Cap
2.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 27, 2023 | 61 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Ardent Health Partners | 23,000 |
| Fortrea Holdings | 19,000 |
| QuidelOrtho | 7,100 |
| Evolent Health | 4,700 |
| UFP Technologies | 3,093 |
| Myriad Genetics | 2,700 |
| Privia Health Group | 1,102 |
| Iovance Biotherapeutics | 557 |
CGON News
- 6 weeks ago - CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC - GlobeNewsWire
- 2 months ago - CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 3 months ago - CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024 - GlobeNewsWire
- 3 months ago - CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 - GlobeNewsWire
- 4 months ago - CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting - GlobeNewsWire
- 6 months ago - CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire